Phenotypes and prognosis

F. Schleich (Liège, Belgium)

Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Session: PG10 Severe asthma in adults: systematic assessment and biological treatment
Session type: Postgraduate Course
Number: 13
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Schleich (Liège, Belgium). Phenotypes and prognosis. International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Markers of early disease and prognosis in COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009


Clinical characteristics of COPD Phenotypes
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


Eosinophils and COVID-19 prognosis
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021


Markers of asthma outcome
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


The evaluation of disease severity/staging for prognosis
Source: Eur Respir Monogr 2016; 71: 97-105
Year: 2016


Clinical features and prognosis of Chinese sarcoidosis patients.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Unique clinicopathological characteristics and favorable prognosis of young patients with non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020

Interstitial lung disease: improving classification and prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021


IL-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Phenotypes and endotypes
Source: Eur Respir Monogr 2018; 81: 133-152
Year: 2018


COPD Phenotypes and Comorbidities
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Prognostic relevance of histological subtypes in lung cancer – Survival in frequent and rare entities
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

Variation in outcomes for M1a Stage Lung cancers- Outcome in Malignant Pleural Effusion significantly worse than patients with Contralateral Lung Nodules
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


Obesity in patients with COVID-19: is it a predictive factor for a poor prognosis?
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021


Influence of Thyroid Transcription Factor 1 expression in prognosis of lung adenocarcinoma
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

Lung cancer in youngers – ethiological implications and prognosis
Source: Eur Respir J 2006; 28: Suppl. 50, 40s
Year: 2006

Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2014; 43: 1529-1530
Year: 2014


Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2013; 42: 750-757
Year: 2013



Factors associated with poor prognostic outcome in acute exacerbation of COPD
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009